A retrospective analysis of the postoperative use of loteprednol etabonate gel 0.5% following laser-assisted in situ keratomileusis or photorefractive keratectomy surgery

MLA

Kait Gilleran, et al. “A Retrospective Analysis of the Postoperative Use of Loteprednol Etabonate Gel 0.5% Following Laser-Assisted in Situ Keratomileusis or Photorefractive Keratectomy Surgery.” Clinical Ophthalmology, Nov. 2015, p. 2089. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2739014bae694dee8e4801a9cb149ccf&authtype=sso&custid=ns315887.

APA

Kait Gilleran, Michael Gordon, Theodore Perl, Eric Donnenfeld, Clifford Salinger, & Mitchell Jackson. (2015). A retrospective analysis of the postoperative use of loteprednol etabonate gel 0.5% following laser-assisted in situ keratomileusis or photorefractive keratectomy surgery. Clinical Ophthalmology, 2089.

Chicago

Kait Gilleran, Michael Gordon, Theodore Perl, Eric Donnenfeld, Clifford Salinger, and Mitchell Jackson. 2015. “A Retrospective Analysis of the Postoperative Use of Loteprednol Etabonate Gel 0.5% Following Laser-Assisted in Situ Keratomileusis or Photorefractive Keratectomy Surgery.” Clinical Ophthalmology, November, 2089. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2739014bae694dee8e4801a9cb149ccf&authtype=sso&custid=ns315887.